KBC Group’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-1,622
| Closed | -$26K | – | 1887 |
|
2024
Q4 | $26K | Buy |
1,622
+359
| +28% | +$5.76K | ﹤0.01% | 1828 |
|
2024
Q3 | $73K | Buy |
1,263
+432
| +52% | +$25K | ﹤0.01% | 1494 |
|
2024
Q2 | $38K | Buy |
831
+65
| +8% | +$2.97K | ﹤0.01% | 1745 |
|
2024
Q1 | $51K | Buy |
+766
| New | +$51K | ﹤0.01% | 1547 |
|